| Title： | Clinical Practice Guidelines for Pregnancy-associated Breast Cancer (PABC): Chinese Society of Breast Surgery (CSBrS) Practice Guidelines 2021 |
| Edition： | Original |
| Classification： | Standard guideline |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | Clinicians specializing in breast diseases in China. |
| Evidence classification method： | The level of evidence grading system was developed by referring to the GRADE system combined with findings in clinical studies in China. The levels are classified as Category I, II, III, and IV to quantify the evaluation of the reliability of the evidence by experts on the compiling committees. |
| Development unit： | Obstetrics and Gynecology Hospital of Fudan University |
| Registration time: | 2021-06-23 |
| Registration number： | IPGRP-2021CN172 |
| Purpose of the guideline: | To standardize the clinical diagnosis and treatment of PABC, based on the Expert consensus on clinical treatment of pregnancy-associated breast cancer (2020 Edition), the Chinese Society of Breast Surgery evaluated the level of evidence in clinical research of PABC by referring to Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. Combined with the clinical characteristics of patients and accessibility of the clinical practice of breast surgery in China, the Clinical Practice Guidelines for Pregnancy-associated Breast Cancer 2021 were created to provide reference for the clinical work of breast surgeons in China. |
Latest registration
